NASDAQ · CPBConsumer StaplesFood & Tobacco

The Campbell's financials

$20.04+3.46%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ4 '26
Aug 2
Q3 '26
May 3
Q2 '26
Feb 1
Q1 '26
Nov 2
Q4 '25
Aug 3
Q3 '25
Apr 27
Q2 '25
Jan 26
Q1 '25
Oct 27
Q4 '24
Jul 28
Q3 '24
Apr 28
Q2 '24
Jan 28
Q1 '24
Oct 29
Revenue$2.14B$2.37B$2.56B$2.68B$2.32B$2.48B$2.69B$2.77B$2.29B$2.37B$2.46B$2.52B
Gross profit$583.0M$650.0M$717.0M$792.0M$705.0M$728.0M$819.0M$867.0M$675.0M$732.0M$776.0M$788.0M
Gross margin27.3%27.5%28.0%29.6%30.4%29.4%30.5%31.3%29.4%30.9%31.6%31.3%
Operating income$4.0M$239.0M$280.0M$345.0M$269.0M$161.0M$368.0M$410.0M$258.0M$278.0M$343.0M$382.0M
Net income-$65.0M$124.0M$145.0M$194.0M$145.0M$66.0M$173.0M$218.0M-$3.0M$133.0M$203.0M$234.0M
Net margin−3.0%5.2%5.7%7.2%6.2%2.7%6.4%7.9%−0.1%5.6%8.3%9.3%
Diluted EPS$-0.21$0.41$0.48$0.65$0.48$0.22$0.58$0.72$-0.01$0.44$0.68$0.78
EBITDA$163.0M$353.0M$385.0M$447.0M$382.0M$276.0M$483.0M$525.0M$279.0M$397.0M$441.0M$480.0M
Operating cash flow$200.0M$99.0M$516.0M$224.0M$259.0M$135.0M$512.0M$225.0M$288.0M$213.0M$510.0M$174.0M
Free cash flow$136.0M$29.0M$416.0M$97.0M$129.0M$50.0M$411.0M$115.0M$147.0M$100.0M$390.0M$31.0M
Diluted shares303.0M299.0M299.0M299.0M301.0M299.0M299.0M301.0M302.0M300.0M299.0M299.0M

Balance sheet

Period endAug 2May 3Feb 1Nov 2Aug 3Apr 27
Cash & equivalents$394.0M$402.0M$561.0M$168.0M$132.0M$143.0M
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$7.14B$7.01B$7.08B$6.97B$6.86B$6.90B
Total assets$15.65B$15.14B$15.35B$15.18B$14.90B$14.83B
Total liabilities$11.49B$11.11B$11.34B$11.22B$10.99B$10.96B
Shareholders' equity$3.85B$4.03B$4.01B$3.96B$3.90B$3.87B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology